Hologics and Grifols agree $14m Enzo settlement

Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

The importance of Minerva Surgical v Hologic

2 February 2021 A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.

Americas

US government urges SCOTUS to deny retroactive IPR suit

13 May 2020 The US Supreme Court should not take up a petition asking whether it’s a violation of the Fifth Amendment for patents issued before the enactment of the American Invents Act to be subjected to inter partes reviews, according to the US government.

Americas

Uni of South Florida researchers accuse Hologic of patent infringement

12 March 2020 The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Hologics and Grifols agree $14m Enzo settlement

More on this story

Editor's picks

Editor's picks

More features